Liu Min, Yan Jin, Wu Yeke, Zhu Hongqiu, Huang Yefang, Wu Keming
Department of Gynecology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Department of Gynecology, Shaanxi University of Chinese Medicine, Xianyang, China.
Front Pharmacol. 2022 Oct 14;13:1026141. doi: 10.3389/fphar.2022.1026141. eCollection 2022.
As an important part of the human intestinal microecology, the intestinal flora is involved in a number of physiological functions of the host. Several studies have shown that imbalance of intestinal flora and its regulation of the intestinal barrier, intestinal immune response, and intestinal flora metabolites (short-chain fatty acids and bile acids) can affect the development and regression of female reproductive disorders. Herbal medicine has unique advantages in the treatment of female reproductive disorders such as polycystic ovary syndrome, endometriosis and premature ovarian insufficiency, although its mechanism of action is still unclear. Therefore, based on the role of intestinal flora in the occurrence and development of female reproduction-related diseases, the progress of research on the diversity, structure and composition of intestinal flora and its metabolites regulated by botanical drugs, Chinese herbal formulas and active ingredients of Chinese herbal medicines is reviewed, with a view to providing reference for the research on the mechanism of action of Chinese herbal medicines in the treatment of female reproductive disorders and further development of new herbal medicines.
作为人类肠道微生态的重要组成部分,肠道菌群参与宿主的多种生理功能。多项研究表明,肠道菌群失衡及其对肠道屏障、肠道免疫反应和肠道菌群代谢产物(短链脂肪酸和胆汁酸)的调节会影响女性生殖系统疾病的发生发展及转归。尽管其作用机制尚不清楚,但中药在治疗多囊卵巢综合征、子宫内膜异位症和卵巢早衰等女性生殖系统疾病方面具有独特优势。因此,基于肠道菌群在女性生殖相关疾病发生发展中的作用,综述了肠道菌群的多样性、结构和组成及其受植物药、中药复方和中药活性成分调节的代谢产物的研究进展,以期为中药治疗女性生殖系统疾病的作用机制研究及新中药的进一步开发提供参考。